Vitrolife AB Statistics

Total Valuation

Vitrolife AB has a market cap or net worth of GBP 2.07 billion. The enterprise value is 2.14 billion.

Market Cap	2.07B
Enterprise Value	2.14B

Important Dates

The last earnings date was Thursday, January 30, 2025.

Earnings Date	Jan 30, 2025
Ex-Dividend Date	Apr 30, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.09%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	74.96M

Valuation Ratios

The trailing PE ratio is 55.99.

PE Ratio	55.99
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.55, with an EV/FCF ratio of 41.84.

EV / Earnings	57.91
EV / Sales	7.99
EV / EBITDA	23.55
EV / EBIT	36.84
EV / FCF	41.84

Financial Position

The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.15.

Current Ratio	3.34
Quick Ratio	2.65
Debt / Equity	0.15
Debt / EBITDA	1.71
Debt / FCF	2.94
Interest Coverage	7.18

Financial Efficiency

Return on equity (ROE) is 3.90% and return on invested capital (ROIC) is 3.20%.

Return on Equity (ROE)	3.90%
Return on Assets (ROA)	2.90%
Return on Invested Capital (ROIC)	3.20%
Return on Capital Employed (ROCE)	4.68%
Revenue Per Employee	232,567
Profits Per Employee	33,058
Employee Count	1,120
Asset Turnover	0.21
Inventory Turnover	3.52

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.89% in the last 52 weeks. The beta is 1.79, so Vitrolife AB's price volatility has been higher than the market average.

Beta (5Y)	1.79
52-Week Price Change	+9.89%
50-Day Moving Average	213.17
200-Day Moving Average	214.94
Relative Strength Index (RSI)	46.35
Average Volume (20 Days)	52,544

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vitrolife AB had revenue of GBP 260.47 million and earned 37.03 million in profits. Earnings per share was 0.27.

Revenue	260.47M
Gross Profit	154.38M
Operating Income	56.51M
Pretax Income	48.65M
Net Income	37.03M
EBITDA	88.41M
EBIT	56.51M
Earnings Per Share (EPS)	0.27

Full Income Statement

Balance Sheet

The company has 81.92 million in cash and 150.77 million in debt, giving a net cash position of -68.85 million.

Cash & Cash Equivalents	81.92M
Total Debt	150.77M
Net Cash	-68.85M
Net Cash Per Share	n/a
Equity (Book Value)	984.52M
Book Value Per Share	7.27
Working Capital	119.23M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 65.46 million and capital expenditures -14.22 million, giving a free cash flow of 51.24 million.

Operating Cash Flow	65.46M
Capital Expenditures	-14.22M
Free Cash Flow	51.24M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 59.27%, with operating and profit margins of 21.70% and 14.21%.

Gross Margin	59.27%
Operating Margin	21.70%
Pretax Margin	18.68%
Profit Margin	14.21%
EBITDA Margin	33.94%
EBIT Margin	21.70%
FCF Margin	19.67%

Dividends & Yields

This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 0.02%.

Dividend Per Share	0.07
Dividend Yield	0.02%
Dividend Growth (YoY)	11.07%
Years of Dividend Growth	2
Payout Ratio	26.32%
Buyback Yield	-0.09%
Shareholder Yield	-0.07%
Earnings Yield	1.79%
FCF Yield	2.47%

Dividend Details

Stock Splits

The last stock split was on May 17, 2018. It was a forward split with a ratio of 5.

Last Split Date	May 17, 2018
Split Type	Forward
Split Ratio	5

Scores

Vitrolife AB has an Altman Z-Score of 4.7.

Altman Z-Score	4.7
Piotroski F-Score	n/a